The review concluded that where hair loss occurs, it is most plausibly explained by the rapid weight loss these drugs produce, which can trigger a temporary shedding condition called telogen effluvium, rather than by the medicine damaging the follicle directly
In these trials, significant weight loss was demonstrated with liraglutide 3.0 mg therapy, compared to placebo (8.0% in SCALE obesity and prediabetes, 6.0% in SCALE-diabetes)
The third receptor target unique to Retatrutide among current obesity compounds
PlexusDx Precision Peptide Genetic Testing may help identify predispositions in GLP-1R, GIPR, FTO, and MC4R pathways, providing context for conversations with your provider about whether oral liquid formulations align with your genetic and metabolic profile, and which dosing strategy warrants initial trial
Unregulated medicines may be unsafe and contain unknown substances
Some analysts predict research-grade pricing will increase as the FDA approval date approaches, since demand will grow while regulatory scrutiny of the grey market intensifies